Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2013
10/03/2013US20130259875 Acth for treatment of amyotrophic lateral sclerosis
10/03/2013US20130259857 Methods for inhibiting fascin
10/03/2013US20130259854 Methods and compositions for reducing the incidence of post-surgical adhesions
10/03/2013US20130259853 Treatment of Acute Ischemic Stroke or Intracranial Bleeding with tPA and Carbamylated Erythropoietin
10/03/2013US20130259852 Lysozyme gel formulations
10/03/2013US20130259851 Use of prokaryotic sphingosine-1-phosphate lyases and of sphingosine-1-phosphate lyases lacking a transmembrane domain for treating hyperproliferative and other diseases
10/03/2013US20130259849 Enhanced Antimicrobial Lytic Activity of a Chimeric Ply187 Endolysin
10/03/2013US20130259848 Enzyme combinations to reduce brain tissue swelling
10/03/2013US20130259834 Compositions and methods for the delivery of therapeutic peptides
10/03/2013US20130259832 Combinations of Hepatitis C Virus Inhibitors
10/03/2013US20130259827 Use of interleukin-15 to treat cardiovascular diseases
10/03/2013US20130259826 Compositions, methods and uses for stimulating immune responses
10/03/2013US20130259824 Treatment for Ischemic Stroke
10/02/2013EP2644203A1 Treatment of tumour diseases
10/02/2013EP2643018A2 Anti-il-6 antibodies for the treatment of oral mucositis
10/02/2013EP2643016A2 Anti-il-6 antibodies for the treatment of anemia
10/02/2013EP2643013A1 Covalently linked interleukin-10
10/02/2013EP2643012A2 Protein delivery from stem cell microcarriers
10/02/2013EP2643011A1 Hla-g isoform for use in the treatment of a disease associated with bone resorption
10/02/2013EP2643010A2 Biologically active complex and its preparation
10/02/2013EP2643009A1 Biodegradable drug delivery composition
10/02/2013EP2643005A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
10/02/2013EP2642978A2 Immunomodulatory compositions comprising hydralazine for the treatment of gastrointestinal disorders
10/02/2013EP2484365B1 Compositions and method for treatment of neovascular diseases
10/02/2013EP2261377B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins
10/02/2013EP2170930B3 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
10/02/2013CN103339253A TOMM34 peptides and vaccines including the same
10/02/2013CN103339149A Modulation of the interaction between SorLA and GDNF-family ligand receptors
10/02/2013CN103339144A Caspase-2 inhibitors
10/02/2013CN103338790A Exendin-4 analogue pegylated with polyethylene glycol or derivative thereof, preparation method thereof, and pharmaceutical composition for preventing or treating diabetes, containing same as active ingredient
10/02/2013CN103338784A Methods for increasing intracellular activity of Hsp70
10/02/2013CN103338783A Compositions and methods for providing or modulating sweet taste and methods of screening therefor
10/02/2013CN103338782A Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans
10/02/2013CN103333941A High purity cerebrolysin vial injection preparation agent
10/02/2013CN103333875A Marine phasolosma esculenta fibrinolytic enzyme, preparation method and applications thereof
10/02/2013CN103333257A Fusion protein possessing excellent protecting effects against high-dose radiation and preparation method thereof
10/02/2013CN103333256A Human acid fibroblast growth factor fusion protein, and coding gene and applications thereof
10/02/2013CN103333255A Long-acting HIV-1 (Human Immunodeficiency Virus-1) membrane fusion inhibitor
10/02/2013CN103333238A mPEG-MAL-aGLP-1 composite
10/02/2013CN103333227A Metastatic tumor deletion protein small-molecule cyclopeptide inhibitor as well as preparation method and application thereof
10/02/2013CN103333225A Antibacterial peptide, preparation method and applications thereof
10/02/2013CN103333223A A novel blood-glucose-reducing polypeptide and applications thereof
10/02/2013CN103333179A Maytansinoid derivatives, preparation method thereof and applications thereof
10/02/2013CN103330945A Application of pingyangmycin combined with sodium hyaluronate in drug for treating lymphatic malformation
10/02/2013CN103330933A Drug composition containing micafungin or salt thereof
10/02/2013CN103330932A Drug composition of micafungin or salt thereof
10/02/2013CN103330213A Tea polyphenol liposoluble microcapsules and preparation method thereof
10/02/2013CN102920664B Preparation method of long-term oral insulin sustained-release microspheres
10/02/2013CN102631667B Nerve regeneration promotion injection and preparation method thereof
10/02/2013CN102627686B Polypeptide with effect of inhibiting activity of fibroblast growth factor receptor 3 and application thereof
10/02/2013CN102161692B Improved hemostatic polypeptide and application thereof
10/02/2013CN101983721B Desert cistanche calcium composition having functions of fatigue resistance and calcium supplement
10/02/2013CN101522705B Antibacterial and antiviral peptides from actinomadura namibiensis
10/01/2013US8546555 Cochleate compositions directed against expression of proteins
10/01/2013US8546546 Anti-Muc 17 antibody
10/01/2013US8546534 Branched chain-containing aromatic compound
10/01/2013US8546532 Synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
10/01/2013US8546531 Methods and reagents for preparing multifunctional probes
10/01/2013US8546530 Process for the manufacture of persilylated peptides
10/01/2013US8546529 Injectable bone regeneration gel containing bone formation enhancing peptide
10/01/2013US8546528 Skin or hair binding peptides
10/01/2013US8546526 Peptide or peptidomimetic compounds containing the Arg-Gly-Asp sequence: new class of diagnostic noninvasive tracers as suitable tools for integrin alpha v beta 3-targeted therapy and imaging; antiproliferation agents; angiogenesis inhibititors; antitumor agents; anticarcinogenic agents; kits
10/01/2013US8546525 Chimeric human beta defensins
10/01/2013US8546524 Smoothened polypeptides and methods of use
10/01/2013US8546523 NPR-B agonists
10/01/2013US8546384 Bonding tissues and cross-linking proteins with naphthalimide compounds
10/01/2013US8546366 Method for inhibition of tumor cell growth using (22R)-5α-lanosta-8,24-dien-3β,15α,21-triol
10/01/2013US8546346 Methods to reprogram splice site selection in pre-messenger RNAs
10/01/2013US8546345 Gene expression inhibition using small interfering RNAs which are specific for the vascular endothelial growth factor (VEGF) gene and the VEGF receptor genes Flt-1 and Flk-1/KDR; diabetic retinopathy, age related macular degeneration and many types of cancer
10/01/2013US8546340 Soothing pharmaceutical or cosmetic composition comprising a peptide that activates HMG-CoA reductase
10/01/2013US8546339 Soothing cosmetic or pharmaceutical composition comprising a peptide which activates HMG-CoA reductase
10/01/2013US8546338 Self-assembling hydrogels based on dicephalic peptide amphiphiles
10/01/2013US8546337 Self-assembling peptide nanoparticles useful as vaccines
10/01/2013US8546336 SMAC peptidometics useful as IAP inhibitors
10/01/2013US8546334 Device having osteoinductive and osteoconductive properties
10/01/2013US8546333 Albumin fibers and fabrics and methods of generating and using same
10/01/2013US8546332 Factor VIII polypeptide having factor VIII:C activity
10/01/2013US8546330 Compositions and methods for treatment of neurodegenerative diseases
10/01/2013US8546328 Liquid formulation of G-CSF conjugate
10/01/2013US8546327 Glucagon/GLP-1 receptor co-agonists
10/01/2013US8546326 low viscosity mixture of: a) at least one neutral diacyl lipid, such as a diacyl glycerol; b) at least one phospholipid, such as a phosphatidyl choline; c) at least one biotolerable solvent, such as an oxygen containing solvent; d) at least one GLP-1 analogue; wherein the pre-formulation forms
10/01/2013US8546325 Composition for improving membrane composition and functioning of cells
10/01/2013US8546324 Short-form human MD-2 as a negative regulator of toll-like receptor 4 signaling
10/01/2013US8546323 Thrombospondin-1 derived peptides and treatment methods
10/01/2013US8546321 IL-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases
10/01/2013US8546319 Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
10/01/2013US8546143 Compositions and methods for inhibiting expression of a target gene
10/01/2013US8546086 Use of neuregulin-β as an indicator and/or target
10/01/2013US8546072 Substrate for assaying β-glucan and/or endotoxin and assay method
10/01/2013US8545927 Lactoferrin-based biomaterials for tissue regeneration and drug delivery
10/01/2013US8545888 Tendon stem cells
10/01/2013US8545868 Drug eluting implantable medical device with hemocompatible and/or prohealing topcoat
10/01/2013US8545858 Porous calcium phosphate bone material
10/01/2013US8545853 Recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted
10/01/2013US8545838 Compositions and methods for cancer immunotherapy
10/01/2013US8545837 Methods and compositions for CNS delivery of iduronate-2-sulfatase
10/01/2013US8545832 Lipid depot formulations
10/01/2013US8545830 Smart segment and a hydrophobic and a hydrophillic biodegradable segment which are hydrolytically or enzymatically degradable; prolonged delivery of therapeutic agents
10/01/2013CA2579605C Topical compositions and methods for epithelial-related conditions
10/01/2013CA2570960C Compositions and methods for treating central precocious puberty
1 ... 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 ... 3163